Colchicine in Chronic Kidney Disease Patients

The ColchiRen study is a phase 3, controlled, prospective, randomized, double-blind, and multicenter clinical trial. Its main objective is to demonstrate the benefit of low-dose colchicine treatment in secondary prevention of cardiovascular events in patients with moderate CKD. As a secondary objective, it aims to explore the potential beneficial anti-inflammatory effect on the progression of CKD.

NCT Number	NCT06998862
Lead Sponsor	Hospital General Universitario Gregorio Marañon
Conditions	Chronic Kidney Disease, Cardiovascular Events
Enrollment	744 participants
Start Date	2025-02-12
Primary Completion	2028-12-30 (estimated)
Study Completion	2028-12-30 (estimated)
Updated on ClinicalTrials.gov	2025-05-31